Why Surgery Partners, Inc.’s (SGRY) Stock Is Up 46.22%
As of Monday, October 26, Surgery Partners, Inc.’s SGRY share price has surged by 46.22%, which has investors questioning if this is right time to sell.Michael Rose
Stock Evaluator: Surgery Partners, Inc. (SGRY)
Surgery Partners, Inc. SGRY
$23.16
0.03
0.13%
November 4, 2026 4:00:00 PM
EST
Volume: 11,092,272
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Commentary & Analysis
Why Surgery Partners, Inc.’s (SGRY) Stock Is Up 46.60%
As of Monday, October 26, Surgery Partners, Inc.’s SGRY share price has surged by 46.60%, which has investors questioning if this is right time to sell.Omar Beirat
3 Undervalued Health Care Providers & Services Stocks for Wednesday, September 30
Discover the top 3 undervalued Health Care Providers & Services stocks for Wednesday, September 30 based on AAII’s Stock Grades.Rosalio Madrigal
Why Surgery Partners, Inc.’s (SGRY) Stock Is Down 5.89%
As of Wednesday, September 23, Surgery Partners, Inc.’s SGRY share price has dipped by 5.89%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Surgery Partners, Inc.’s (SGRY) Stock Is Up 9.04%
As of Tuesday, September 22, Surgery Partners, Inc.’s SGRY share price has surged by 9.04%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,000.2 | $1,879.6 | 60% |
|
| Shares Out (Mil) | 128.8 | 79.2 | 67% |
|
| Institutional Ownership | 97.6% | 85.6% | 74% |
|
| Float (Mil) | 58.8 | 58.0 | 50% |
|
| Beta | 1.92 | 0.78 | 91% |
|
| Avg Daily Volume (000s) | 9,444 | 642 | 96% |
|
| Price Change (52-week) |
5.5% | 79.2% | 56% |
|
| Growth | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.2% | 10.4% | 66% |
|
| Net Income (5yr) | 7.7% | (0.7%) | 52% |
|
| EPS (5yr) | 28.1% | 2.1% | 79 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.4%) | (17.1%) | 49% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 5 | |
| Current EPS | $0.125 | $0.356 | $0.210 | |
| Month Ago EPS | $0.123 | $0.350 | $0.280 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $0.133 | $0.465 | $0.669 | |
| Year/Year Chg | (204.2%) | (158.2%) | (180.2%) | |
| Financials | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,366 | $1,505 | 68% |
|
| Net Income (TTM) (Mil) | ($89) | $32 | 12% |
|
| EPS (TTM) | ($0.692) | $0.300 | 25% |
|
| Operating Cash Flow (TTM) (Mil) | $258 | $165 | 62% |
|
| Net Cash Flow (TTM) (Mil) | ($33) | $2 | 23% |
|
| Long-Term Debt (Q1) (Mil) | $3,924 | $375 | 82% |
|
| Enterprise Value (Q1) (Mil) | $7,537 | $2,361 | 69% |
|
| Valuation | SGRY | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.80 | 2.87 | 50% |
|
| P/E | na | 26.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | SGRY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 22.5% | 27.4% | 25% |
|
| Net Margin | (2.6%) | 1.2% | 28% |
|
| ROA | (1.1%) | 2.2% | 36% |
|
| ROE | (5.2%) | 6.9% | 31% |
|
| Liabilities to Assets | 56.9% | 62.7% | 50% |
|
| F-Score | 5 | 5 | 50% |
|
Passing Stock Screens
As of 11/3/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.9% |
| +/- S&P 500: | -0.5 |
